Kalinsky K, Accordino MK, Chiuzan C, Mundi PS, et al. Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Tr J Clin Oncol 2023 May 19:JCO2202392. doi: 10.1200/JCO.22.02392.
PMID: 37207300